QNCX
QNCX
NASDAQ · Biotechnology

Quince Therapeutics Inc

$31.17
+2.17 (+7.48%)
As of Sep 29, 10:27 PM ET ·
Analyst Consensus
Buy
13
Analysts
Moderate
Coverage
Buy 9 69%
Hold 4 31%
Sell 0 0%
Price Target
Analyst Price Target +28.8% upside
Low Target $31.69
Average Target $40.14
High Target $63.06
Current Price $31.17
Current
$31.17
Target
$40.14
$31.69 $40.14 avg $63.06
Scenario Analysis
Bear Case
$31.69
1.7%
Low target
Base Case
$40.14
+28.8%
Avg target
Bull Case
$63.06
+102.3%
High target
Risk/Reward
61.3x
Highly favorable
Price in Context
52-Week High
$910.00
-96.6% from high
52-Week Low
$15.10
+106.4% from low
Target vs 52W High
$40.14
-95.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.2%
AMGN
Amgen Inc
Hold 43 47% $190.87 -54.9%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +139.7%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -16.8%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -89.8%
MRNA
Moderna Inc
Hold 30 37% $149.45 -26.5%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -65.5%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.2%